1. Home
  2. CYTK vs CADE Comparison

CYTK vs CADE Comparison

Compare CYTK & CADE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • CADE
  • Stock Information
  • Founded
  • CYTK 1997
  • CADE 1876
  • Country
  • CYTK United States
  • CADE United States
  • Employees
  • CYTK N/A
  • CADE N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • CADE Major Banks
  • Sector
  • CYTK Health Care
  • CADE Finance
  • Exchange
  • CYTK Nasdaq
  • CADE Nasdaq
  • Market Cap
  • CYTK 5.6B
  • CADE 6.4B
  • IPO Year
  • CYTK 2004
  • CADE N/A
  • Fundamental
  • Price
  • CYTK $39.48
  • CADE $27.88
  • Analyst Decision
  • CYTK Strong Buy
  • CADE Buy
  • Analyst Count
  • CYTK 17
  • CADE 12
  • Target Price
  • CYTK $81.63
  • CADE $38.17
  • AVG Volume (30 Days)
  • CYTK 2.6M
  • CADE 1.5M
  • Earning Date
  • CYTK 05-07-2025
  • CADE 04-21-2025
  • Dividend Yield
  • CYTK N/A
  • CADE 3.92%
  • EPS Growth
  • CYTK N/A
  • CADE N/A
  • EPS
  • CYTK N/A
  • CADE 2.77
  • Revenue
  • CYTK $18,474,000.00
  • CADE $1,721,725,000.00
  • Revenue This Year
  • CYTK $55.84
  • CADE $12.15
  • Revenue Next Year
  • CYTK $659.85
  • CADE $7.04
  • P/E Ratio
  • CYTK N/A
  • CADE $10.07
  • Revenue Growth
  • CYTK 145.34
  • CADE 49.06
  • 52 Week Low
  • CYTK $32.74
  • CADE $25.22
  • 52 Week High
  • CYTK $68.76
  • CADE $40.20
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 46.41
  • CADE 41.97
  • Support Level
  • CYTK $37.79
  • CADE $27.47
  • Resistance Level
  • CYTK $40.22
  • CADE $29.09
  • Average True Range (ATR)
  • CYTK 3.16
  • CADE 1.46
  • MACD
  • CYTK 0.25
  • CADE 0.08
  • Stochastic Oscillator
  • CYTK 61.55
  • CADE 49.63

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

Share on Social Networks: